Quipt Home Medical CORP

Quipt Home Medical Corp. has completed its acquisition by affiliates of Kingswood and Forager for US$3.65 per share, totaling approximately $173 million, transitioning to a privately held entity.

Quipt Home Medical Corp. shareholders overwhelmingly approved the plan of arrangement for its acquisition by affiliates of Kingswood Capital Management, L.P. and Forager Capital Management, LLC for US$3.65 per share.

Quipt Home Medical Corp. announced the expiration of the HSR Act waiting period, satisfying a key condition for its acquisition by Purchaser for $3.65 per share in cash.

Quipt Home Medical Corp. announced a special shareholder meeting on March 3, 2026, to vote on a proposed transaction involving 1567208 B.C. LTD and REM Aggregator, LLC.

Quipt Home Medical Corp. announced its fourth quarter and fiscal year 2025 financial results, showing strong Q4 revenue growth but a slight annual decline.

Quipt Home Medical Corp. has entered into a definitive agreement to be acquired by affiliates of Kingswood Capital Management and Forager Capital Management for US$3.65 per share in an all-cash transaction.

Quipt Home Medical Corp. reported a significant net loss and revenue decline for the quarter ended June 30, 2025, impacted by Medicare rate changes and a cybersecurity incident.

Quipt Home Medical Corp. reports a decrease in revenue for the three and six months ended March 31, 2025, impacted by the discontinuation of Medicare 75/25 blended rate, cybersecurity incidents, and seasonal weaknesses.

Quipt Home Medical Corp. experienced a slight decrease in revenue but reduced its net loss in the first quarter of fiscal year 2025, amidst industry challenges and strategic adjustments.

Quipt Home Medical Corp. files an amended annual report to disclose corporate governance, executive compensation, and beneficial ownership details, confirming a pending acquisition at US$3.65 per share.

Quipt Home Medical Corp. reports a net loss for fiscal year 2025, impacted by Medicare reimbursement changes and a cybersecurity incident, while pursuing strategic acquisitions and a definitive take-private transaction.

Quipt Home Medical Corp. saw a 16% increase in revenue for fiscal year 2024, reaching $245.9 million, while navigating challenges including Medicare reimbursement changes and a cybersecurity incident.

Quipt Home Medical Corp. Director Brian Wessel reported the disposition of all his direct and indirect common shares and the forfeiture/cancellation of RSUs and options due to a plan of arrangement at $3.65 per share.

Quipt Home Medical Corp.'s Chief Accounting Officer, Thomas Roehrig, disposed of all common shares and options as part of a plan of arrangement at $3.65 per share.

Quipt Home Medical Corp.'s Chief Compliance Officer, Mark Alan Miles, disposed of all his common shares and options as part of a plan of arrangement at US$3.65 per share.

Quipt Home Medical Corp. Director Mark Alan Greenberg disposed of all his common shares and options as part of a plan of arrangement at $3.65 per share.

Quipt Home Medical Corp. Executive VP Operations, Patrick Dennis Gamble, disposed of all his common shares and stock options as part of a plan of arrangement where the company was acquired for $3.65 per share.

Quipt Home Medical Corp. CEO Gregory John Crawford disposed of all his direct and indirect holdings as the company was acquired for US$3.65 per share.

Quipt Home Medical Corp. announced the expiration of the HSR waiting period for its acquisition by 1567208 B.C. Ltd. for $3.65 per share in cash, moving the transaction closer to completion.

Quipt Home Medical Corp. announced a special shareholder meeting on March 3, 2026, to vote on a proposed transaction involving 1567208 B.C. LTD and REM Aggregator, LLC.

Quipt Home Medical Corp. will be acquired by affiliates of Kingswood Capital Management and Forager Capital Management for US$3.65 per share in an all-cash transaction.

Quipt Home Medical Corp. and Kanen Wealth Management have entered into a cooperation agreement, resolving a potential proxy battle and focusing on enhancing shareholder value.

Quipt Home Medical acknowledges notice from Kanen Wealth Management (KWM) regarding their intent to solicit proxies for alternative director candidates and reaffirms its commitment to shareholder value and corporate governance.

Quipt Home Medical is addressing a proxy solicitation from Philotimo Fund, which intends to nominate its own director candidates, potentially leading to additional costs and revised proxy materials.

The acquisition of Quipt Home Medical Corp. by 1567208 B.C. LTD and REM Aggregator, LLC has been completed, with all common shares acquired for $3.65 each.

Quipt Home Medical Corp. will be acquired by REM Aggregator, LLC and 1567208 B.C. Ltd. for $3.65 per share in cash via a plan of arrangement.

Lakeview Opportunity Fund and its affiliates have disclosed a 7.9% beneficial ownership stake in Quipt Home Medical Corp., citing an attractive investment opportunity.

Forager Capital Management has submitted an updated, immediately actionable proposal to acquire all outstanding shares of Quipt Home Medical Corp. for $3.10 per share in cash.

Forager Capital Management has publicly denied Quipt Home Medical Corp.'s characterization of its May 17, 2025 offer as 'unsolicited' and is demanding a retraction of what it calls 'false and misleading statements' and the termination of a Non-Disclosure and Standstill Agreement.

Kanen Wealth Management LLC and its affiliated funds have filed an amended Schedule 13D, disclosing that their collective beneficial ownership in Quipt Home Medical Corp. has fallen below the 5% threshold as of May 20, 2025.

Glazer Capital, LLC and Paul J. Glazer have filed a Schedule 13G, reporting no beneficial ownership of Quipt Home Medical Corp. common shares as of March 31, 2026.

Claret Asset Management Corporation has reported an increased beneficial ownership of 7.33% in Quipt Home Medical Corp. common shares.

Glazer Capital, LLC and Paul J. Glazer have reported a 5.62% beneficial ownership stake in Quipt Home Medical Corp., totaling 2,476,409 common shares.

Claret Asset Management Corporation has filed an amended Schedule 13G, reporting a beneficial ownership of 10.38% of Quipt Home Medical Corp.'s common shares as of December 31, 2024.